Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04497129 · ClinicalTrials.gov registry record · NA
ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)
A NA study, sponsored by ROM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT04497129 is a NA study that has completed, run by ROM Technologies. The registered enrollment target is 300 participants.
The verdict
NCT04497129, a NA study, has completed, sponsored by ROM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
ROMTech is focused on transforming the healthcare market by delivering lower extremity rehabilitation systems that are effective, efficient for patient use, cost-effective, and provide better patient outcomes while simultaneously decreasing rehabilitation and overall recovery times.
Interventions
- DEVICE ROMTech PortableConnect
- DEVICE Traditional Rehabilitation and CPM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04497129
The ClinicalTrials.gov registry entry for NCT04497129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ROM Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ROMTech PortableConnect is the first listed.
NCT04497129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04497129 about?
NCT04497129 is a clinical study titled "ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)". ROMTech is focused on transforming the healthcare market by delivering lower extremity rehabilitation systems that are effective, efficient for patient use, cost-effective, and provide better patient outcomes while simultaneously decreasing rehabilitation and overall recovery times.
What is the current status of trial NCT04497129?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-08-17. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04497129?
The interventions under investigation include: ROMTech PortableConnect (DEVICE), Traditional Rehabilitation and CPM Device (DEVICE).
Who is sponsoring clinical trial NCT04497129?
This trial is sponsored by ROM Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.